Download PDF
Thorac Cardiovasc Surg 2024; 72(01): 040-050
DOI: 10.1055/s-0042-1755205
Review Article

The Burden of Cardiovascular Diseases Due to COVID-19 Pandemic

Md Sadique Hussain
1   Department of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, India
,
Ganesh Sharma
1   Department of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, India
› Author Affiliations
› Further Information
    Permissions and Reprints All articles of this category

Abstract

The coronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that produces respiratory symptoms and has serious consequences for people's cardiovascular systems (CVS). It is a severe issue and a major task not only for health care experts but also for governments to contain this pandemic. SARS-CoV-2 is the seventh member of the human coronavirus family to be implicated in this zoonotic outbreak. COVID-19's CV interactions are comparable to those of SARS-CoV, Middle East respiratory syndrome (MERS-CoV), and influenza. Those who have COVID-19 and underlying cardiovascular diseases (CVDs) are at a higher risk of serious illness and mortality, and disease has been linked to several direct and indirect CV consequences. COVID-19 causes CVDs such as arrhythmias, cardiac arrest, cardiogenic shock, myocarditis, stress-cardiomyopathy, and acute myocardial damage (AMD) as a consequence of acute coronary syndrome. The provision of CV care may expose health care professionals to risk as they become hosts or vectors of viral transmission. It binds to the angiotensin-converting enzyme receptor, causing constitutional and pulmonary signs in the beginning, and then as the infection advances, it affects other organs such as the gastrointestinal tract, CVS, neurological system, and so on. COVID-19 mortality is increased by underlying CVDs comorbidities.

Keywords

cardiogenic shock - stress-cardiomyopathy - ACE-2 - mortality


Publication History

Received: 02 March 2022

Accepted: 14 June 2022

Article published online:
20 August 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Pradhan D, Biswasroy P, Kumar Naik P, Ghosh G, Rath G. A review of current interventions for COVID-19 prevention. Arch Med Res 2020; 51 (05) 363-374
    CrossrefPubMedGoogle Scholar
  • 2 Abdel-Latif RG, Mohammed S, Elgendy IY. Statin therapy and SAR-COV-2: an available and potential therapy?. Eur Heart J Cardiovasc Pharmacother 2020; 6 (05) 333-334
    CrossrefPubMedGoogle Scholar
  • 3 Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis – a review of current methods. Biosens Bioelectron 2021; 172: 112752
    CrossrefPubMedGoogle Scholar
  • 4 Ansari MAH, Hussain MS. Mohit. A mini review of the COVID-19, vaccine platform and future preparedness. Int J Sci Res Sci Technol 2021; 8: 224-229
    CrossrefPubMedGoogle Scholar
  • 5 Rattanachaikunsopon P, Phumkhachorn P. A Glimpse of COVID-19 Situation in Thailand. Int J Curr Res Rev 2020; 12 (23) 1-2
    CrossrefPubMedGoogle Scholar
  • 6 Tan W, Zhao X, Ma X. et al. A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019-2020. China CDC Wkly 2020; 2 (04) 61-62
    CrossrefPubMedGoogle Scholar
  • 7 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
    CrossrefPubMedGoogle Scholar
  • 8 Pandey SC, Pande V, Sati D, Upreti S, Samant M. Vaccination strategies to combat novel corona virus SARS-CoV-2. Life Sci 2020; 256: 117956
    CrossrefPubMedGoogle Scholar
  • 9 Driggin E, Madhavan MV, Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 75 (18) 2352-2371
    CrossrefPubMedGoogle Scholar
  • 10 Lala A, Johnson KW, Januzzi JL. et al; Mount Sinai COVID Informatics Center. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 2020; 76 (05) 533-546
    CrossrefPubMedGoogle Scholar
  • 11 Kaushik A, Patel S, Dubey K. Digital cardiovascular care in COVID-19 pandemic: a potential alternative?. J Card Surg 2020; 35 (12) 3545-3550
    CrossrefPubMedGoogle Scholar
  • 12 Mottola FF, Verde N, Ricciolino R. et al. Cardiovascular system in COVID-19: simply a viewer or a leading actor?. Life (Basel) 2020; 10 (09) 1-13
    PubMedGoogle Scholar
  • 13 Kang Y, Chen T, Mui D. et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart 2020; 106 (15) 1132-1141
    CrossrefPubMedGoogle Scholar
  • 14 Chen Q, Xu L, Dai Y. et al. Cardiovascular manifestations in severe and critical patients with COVID-19. Clin Cardiol 2020; 43 (07) 796-802
    CrossrefPubMedGoogle Scholar
  • 15 O'Gallagher K, Shek A, Bean DM. et al. Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19. BMC Cardiovasc Disord 2021; 21 (01) 327
    CrossrefPubMedGoogle Scholar
  • 16 Hussain S, Mohapatra C, Trivedi K, Gupta L, Baweja H. SARS-CoV-2 and the gastrointestinal disorders. TMR Theory and Hypothesis 2021; 4 (04) 549-558
    CrossrefPubMedGoogle Scholar
  • 17 Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol 2020; 215: 108427
    CrossrefPubMedGoogle Scholar
  • 18 Hussain S. Targeting SARS-CoV-2 with therapeutic monoclonal antibodies. Precision Med Res 2021; 3 (04) 18
    CrossrefPubMedGoogle Scholar
  • 19 Madabhavi I, Sarkar M, Kadakol N. COVID-19: a review. Monaldi Arch Chest Dis 2020; 90 (02) 248-258
    CrossrefPubMedGoogle Scholar
  • 20 Hussain MS, Sharma P, Dhanjal DS. et al. Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases. Chem Biol Interact 2021; 348: 109637
    CrossrefPubMedGoogle Scholar
  • 21 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13) 1239-1242
    CrossrefPubMedGoogle Scholar
  • 22 Cheung KS, Hung IFN, Chan PPY. et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 2020; 159 (01) 81-95
    CrossrefPubMedGoogle Scholar
  • 23 Nassar M, Daoud A, Nso N. et al. Diabetes mellitus and COVID-19: review article. Diabetes Metab Syndr 2021; 15 (06) 102268
    CrossrefPubMedGoogle Scholar
  • 24 Kumari R, Kaur J, Hussain S. Management of diabetes with COVID-19: a review. Int J Pharm Sci 2020; 12: 1-6
    PubMedGoogle Scholar
  • 25 Rawat S, Hussain MS, Mohapatra C, Kaur G. An overview of monoclonal antibodies and their therapeutic applications. Natural Volatiles & Essential Oils 2021; 8 (06) 4121-4130
    PubMedGoogle Scholar
  • 26 Lin HXJ, Cho S, Meyyur Aravamudan V. et al. Remdesivir in coronavirus disease 2019 (COVID-19) treatment: a review of evidence. Infection 2021; 49 (03) 401-410
    CrossrefPubMedGoogle Scholar
  • 27 Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020; 22 (01) 19
    CrossrefPubMedGoogle Scholar
  • 28 Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill 2020; 25 (04) 2000058
    CrossrefPubMedGoogle Scholar
  • 29 Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020; 24: 91-98
    CrossrefPubMedGoogle Scholar
  • 30 Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19: implications for the cardiovascular system. Circulation 2020; 142 (01) 68-78
    CrossrefPubMedGoogle Scholar
  • 31 Channappanavar R, Zhao J, Perlman S. T cell-mediated immune response to respiratory coronaviruses. Immunol Res 2014; 59 (1-3): 118-128
    CrossrefPubMedGoogle Scholar
  • 32 Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens 2020; 9 (03) E231
    CrossrefPubMedGoogle Scholar
  • 33 Mohit HMS. Potential role of curcumin as a treatment option for COVID-19: a review. Plant Arch 2021; 21 (01) 296-305
    PubMedGoogle Scholar
  • 34 Akhigbe R, Hamed M. Possible links between COVID-19 and male fertility. Asian Pac J Reprod 2020; 9 (05) 211
    CrossrefPubMedGoogle Scholar
  • 35 Husssain MS, , Mohit, Pamma P, Kumari B. Treatment modalities of the COVID-19 pandemic through repurposed drugs and status of vaccines. International Journal of Applied Pharmaceutics 2021; 13 (02) 48-58
    CrossrefPubMedGoogle Scholar
  • 36 Petrovic V, Radenkovic D, Radenkovic G, Djordjevic V, Banach M. Pathophysiology of cardiovascular complications in COVID-19. Front Physiol 2020; 11: 575600
    CrossrefPubMedGoogle Scholar
  • 37 Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020; 17 (09) 543-558
    CrossrefPubMedGoogle Scholar
  • 38 Costa IBSDS, Bittar CS, Rizk SI. et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol 2020; 114 (05) 805-816
    PubMedGoogle Scholar
  • 39 Barison A, Aimo A, Castiglione V. et al. Cardiovascular disease and COVID-19: les liaisons dangereuses. Eur J Prev Cardiol 2020; 27 (10) 1017-1025
    CrossrefPubMedGoogle Scholar
  • 40 Chen T, Wu D, Chen H. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: m1091
    CrossrefPubMedGoogle Scholar
  • 41 Guo T, Fan Y, Chen M. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5 (07) 811-818
    CrossrefPubMedGoogle Scholar
  • 42 Bandyopadhyay D, Akhtar T, Hajra A. et al. COVID-19 pandemic: cardiovascular complications and future implications. Am J Cardiovasc Drugs 2020; 20 (04) 311-324
    CrossrefPubMedGoogle Scholar
  • 43 Lee CCE, Ali K, Connell D. et al. COVID-19-associated cardiovascular complications. Diseases 2021; 9 (03) 47
    CrossrefPubMedGoogle Scholar
  • 44 Samidurai A, Das A. Cardiovascular complications associated with COVID-19 and potential therapeutic strategies. Int J Mol Sci 2020; 21 (18) 1-28
    CrossrefPubMedGoogle Scholar
  • 45 Ganatra S, Hammond SP, Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncol 2020; 2 (02) 350-355
    CrossrefPubMedGoogle Scholar
  • 46 Shi S, Qin M, Shen B. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; 5 (07) 802-810
    CrossrefPubMedGoogle Scholar
  • 47 Su YB, Kuo MJ, Lin TY. et al. Cardiovascular manifestation and treatment in COVID-19. J Chin Med Assoc 2020; 83 (08) 704-709
    CrossrefPubMedGoogle Scholar
  • 48 Bae S, Kim SR, Kim MN, Shim WJ, Park SM. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart 2021; 107 (05) 373-380
    CrossrefPubMedGoogle Scholar
  • 49 Yang J, Zheng Y, Gou X. et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91-95
    CrossrefPubMedGoogle Scholar
  • 50 Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E. et al; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020; 34: 101623
    CrossrefPubMedGoogle Scholar
  • 51 Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature. Am J Infect Control 2021; 49 (02) 238-246
    CrossrefPubMedGoogle Scholar
  • 52 He F, Quan Y, Lei M. et al. Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases. Aging Dis 2020; 11 (04) 763-769
    CrossrefPubMedGoogle Scholar
  • 53 Adão R, Guzik TJ. Inside the heart of COVID-19. Cardiovasc Res 2020; 116 (06) e59-e61
    CrossrefPubMedGoogle Scholar
  • 54 Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res 2020; 126 (10) 1443-1455
    CrossrefPubMedGoogle Scholar
  • 55 Judson GL, Kelemen BW, Njoroge JN, Mahadevan VS. Cardiovascular implications and therapeutic considerations in COVID-19 infection. Cardiol Ther 2020; 9 (02) 293-305
    CrossrefPubMedGoogle Scholar
  • 56 Liu K, Fang YY, Deng Y. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020; 133 (09) 1025-1031
    CrossrefPubMedGoogle Scholar
  • 57 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323 (11) 1061-1069
    CrossrefPubMedGoogle Scholar
  • 58 Babapoor-Farrokhran S, Rasekhi RT, Gill D, Babapoor S, Amanullah A. Arrhythmia in COVID-19. SN Compr Clin Med 2020; 2 (09) 1430-1435
    CrossrefPubMedGoogle Scholar
  • 59 Guzik TJ, Mohiddin SA, Dimarco A. et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020; 116 (10) 1666-1687
    CrossrefPubMedGoogle Scholar
  • 60 Boukhris M, Hillani A, Moroni F. et al. Cardiovascular implications of the COVID-19 pandemic: a global perspective. Can J Cardiol 2020; 36 (07) 1068-1080
    CrossrefPubMedGoogle Scholar
  • 61 Cheng P, Zhu H, Witteles RM. et al. Cardiovascular risks in patients with COVID-19: potential mechanisms and areas of uncertainty. Curr Cardiol Rep 2020; 22 (05) 34
    CrossrefPubMedGoogle Scholar
  • 62 Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. Cardiovascular health and disease in the context of COVID-19. Cardiol Res 2021; 12 (02) 67-79
    CrossrefPubMedGoogle Scholar
  • 63 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062
    CrossrefPubMedGoogle Scholar
  • 64 Arentz M, Yim E, Klaff L. et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020; 323 (16) 1612-1614
    CrossrefPubMedGoogle Scholar
  • 65 Ranard LS, Fried JA, Abdalla M. et al. Approach to acute cardiovascular complications in COVID-19 infection. Circ Heart Fail 2020; 13 (07) e007220
    CrossrefPubMedGoogle Scholar
  • 66 Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 2020; 8 (07) 681-686
    CrossrefPubMedGoogle Scholar
  • 67 Jonasson F, Arnarsson A, Eiríksdottir G. et al. Prevalence of age-related macular degeneration in old persons: age, gene/environment susceptibility Reykjavik Study. Ophthalmology 2011; 118 (05) 825-830
    CrossrefPubMedGoogle Scholar
  • 68 Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 2021; 42 (02) 206
    CrossrefPubMedGoogle Scholar
  • 69 Khalid N, Chen Y, Case BC. et al. COVID-19 (SARS-CoV-2) and the heart - an ominous association. Cardiovasc Revasc Med 2020; 21 (08) 946-949
    CrossrefPubMedGoogle Scholar
  • 70 Liu W, Liu Z, Li YC. COVID-19-related myocarditis and cholinergic anti-inflammatory pathways. Hellenic J Cardiol 2021; 62 (04) 265-269
    CrossrefPubMedGoogle Scholar
  • 71 Sawalha K, Abozenah M, Kadado AJ. et al. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revasc Med 2021; 23: 107-113
    CrossrefPubMedGoogle Scholar
  • 72 Magadum A, Kishore R. Cardiovascular manifestations of COVID-19 infection. Cells 2020; 9 (11) E2508
    CrossrefPubMedGoogle Scholar
  • 73 Kim IC, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J 2020; 41 (19) 1859
    CrossrefPubMedGoogle Scholar
  • 74 Greenberg A, Pemmasani G, Yandrapalli S, Frishman WH. Cardiovascular and cerebrovascular complications with COVID-19. Cardiol Rev 2021; 29 (03) 143-149
    CrossrefPubMedGoogle Scholar
  • 75 Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020; 38 (07) 1504-1507
    CrossrefPubMedGoogle Scholar
  • 76 Chung MK, Zidar DA, Bristow MR. et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res 2021; 128 (08) 1214-1236
    CrossrefPubMedGoogle Scholar
  • 77 Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N. Cardiovascular system is at higher risk of affecting by COVID-19. Acta Biomed 2020; 91 (03) e2020018
    PubMedGoogle Scholar
  • 78 Wu Q, Zhou L, Sun X. et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 2017; 7 (01) 9110
    CrossrefPubMedGoogle Scholar
  • 79 Khawaja SA, Mohan P, Jabbour R. et al. COVID-19 and its impact on the cardiovascular system. Open Heart 2021; 8 (01) e001472
    CrossrefPubMedGoogle Scholar
  • 80 Carter P, Anderson M, Mossialos E, Abel-Smith B. Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective. Eur Heart J 2020; 41 (27) 2516-2518
    CrossrefPubMedGoogle Scholar
  • 81 Dolinski D, Dolinska B, Zmaczynska-Witek B, Banach M, Kulesza W. Unrealistic optimism in the time of coronavirus pandemic: may it help to kill, if so-whom: disease or the person?. J Clin Med 2020; 9 (05) E1464
    CrossrefPubMedGoogle Scholar
  • 82 Zheng S, Fan J, Yu F. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 2020; 369: m1443
    CrossrefPubMedGoogle Scholar
  • 83 Satterfield BA, Bhatt DL, Gersh BJ. Publisher correction: cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol 2022; 19 (05) 342
    CrossrefPubMedGoogle Scholar
  • 84 Findling MG, Blendon RJ, Benson JM. Delayed care with harmful health consequences—reported experiences from national surveys during coronavirus disease 2019. JAMA Health Forum 2020; 1 (12) e201463-e201463
    CrossrefPubMedGoogle Scholar
  • 85 Shah SMI, Bin Zafar MD, Yasmin F. et al. Exploring the impact of the COVID-19 pandemic on cardiac surgical services: a scoping review. J Card Surg 2021; 36 (09) 3354-3363
    CrossrefPubMedGoogle Scholar
  • 86 Garcia S, Dehghani P, Grines C. et al; Society for Cardiac Angiography and Interventions, the Canadian Association of Interventional Cardiology, and the American College of Cardiology Interventional Council. Initial findings from the North American COVID-19 Myocardial Infarction Registry. J Am Coll Cardiol 2021; 77 (16) 1994-2003
    CrossrefPubMedGoogle Scholar
  • 87 Gerc V, Masic I, Salihefendic N, Zildzic M. Cardiovascular diseases (CVDs) in COVID-19 pandemic era. Mater Sociomed 2020; 32 (02) 158-164
    CrossrefPubMedGoogle Scholar
  • 88 Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Coll Cardiol 2021; 77 (02) 159-169
    CrossrefPubMedGoogle Scholar
  • 89 Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J 2020; 41 (19) 1852-1853
    CrossrefPubMedGoogle Scholar
  • 90 Masroor S. Collateral damage of COVID-19 pandemic: delayed medical care. J Card Surg 2020; 35 (06) 1345-1347
    CrossrefPubMedGoogle Scholar
  • 91 Ivert T, Dalén M. Dismal outcome if delayed cardiac surgery because of coronavirus disease 2019. Interact Cardiovasc Thorac Surg 2022; ivac072
    CrossrefPubMedGoogle Scholar
  • 92 BK A, Chaudhuri D. A review of acute myocardial injury in coronavirus disease 2019. Cureus 2020; 12 (06) e8426
    PubMedGoogle Scholar